Publications by authors named "Djamila E Issa"

Claim this Profile
F
Fatigue, Neuropathy and Psychological Distress and Their Association With Health-Related Quality of Life in Survivors of Diffuse Large B-Cell Lymphoma: A Prospective Cohort Study and Comparison With a Normative Population.
Suzanne I M Neppelenbroek, Afke Ekels, Marie José Kersten, Djamila E Issa, Noortje Thielen

Hematol Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atezolizumab consolidation in patients with high-risk diffuse large B-cell lymphoma in complete remission after R-CHOP.
Marcel Nijland, Djamila E Issa, Johanna A A Bult, Dries Deeren, Gerjo A Velders

Blood Adv· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The course of self-perceived cognitive functioning among patients with lymphoma and the co-occurrence with fatigue and psychological distress.
Afke Ekels, Simone Oerlemans, Sanne B Schagen, Djamila E Issa, Noortje Thielen

J Cancer Surviv· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of comorbidity on health-related quality of life in newly diagnosed patients with lymphoma or multiple myeloma: results from the PROFILES-registry.
Afke Ekels, Lonneke V van de Poll-Franse, Djamila E Issa, Mels Hoogendoorn, Marten R Nijziel

Ann Hematol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative effectiveness of 6x R-CHOP21 versus 6x R-CHOP21 + 2 R for patients with advanced-stage diffuse large B-cell lymphoma.
Carolien C H M Maas, David van Klaveren, Müjde Durmaz, Otto Visser, Djamila E Issa

Blood Cancer J· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health care utilization up to 11 years after diagnosis among patients with a hematologic malignancy and its association with socioeconomic position.
Afke Ekels, Lonneke V van de Poll-Franse, Djamila E Issa, Margriet Oosterveld, René van der Griend

J Cancer Surviv· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line venetoclax combinations versus chemoimmunotherapy in fit patients with chronic lymphocytic leukaemia (GAIA/CLL13): 4-year follow-up from a multicentre, open-label, randomised, phase 3 trial.
Moritz Fürstenau, Arnon P Kater, Sandra Robrecht, Julia von Tresckow, Can Zhang, Djamila E Issa

Lancet Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment and outcomes for patients with relapsed or refractory diffuse large B-cell lymphoma: a contemporary, nationwide, population-based study in the Netherlands.
Elise R A Pennings, Müjde Durmaz, Otto Visser, Eduardus F M Posthuma, Djamila E Issa

Blood Cancer J· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fixed-duration venetoclax plus obinutuzumab improves quality of life and geriatric impairments in FCR-unfit patients with CLL.
Lina van der Straten, Claudia A M Stege, Sabina Kersting, Kazem Nasserinejad, Julie Dubois, Djamila E Issa

Blood· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No sex differential in relative survival among older patients with DLBCL treated with R-CHOP21: a population-based study.
Emma E Geerdes, Müjde Durmaz, Pieternella J Lugtenburg, Martine E D Chamuleau, Otto Visser, Djamila E Issa

Blood Adv· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ixazomib, daratumumab and low-dose dexamethasone in intermediate-fit patients with newly diagnosed multiple myeloma: an open-label phase 2 trial.
Kaz Groen, Claudia A M Stege, Kazem Nasserinejad, Koen de Heer, Roel J W van Kampen, Djamila E Issa

EClinicalMedicine· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
R-CEOP as first-line treatment for anthracycline-ineligible patients with diffuse large B-cell lymphoma.
Diana Al-Sarayfi, Frederik O Meeuwes, Müjde Durmaz, Djamila E Issa, Rolf E Brouwer

Blood Cancer J· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistent symptoms of fatigue, neuropathy and role-functioning impairment among indolent non-Hodgkin lymphoma survivors: A longitudinal PROFILES registry study.
Afke Ekels, Lonneke V van de Poll-Franse, Eduardus F M Posthuma, Jacobien Kieffer, Djamila E Issa

Br J Haematol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venetoclax consolidation after fixed-duration venetoclax plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (HOVON 139/GiVe): primary endpoint analysis of a multicentre, open-label, randomised, parallel-group, phase 2 trial.
Sabina Kersting, Julie Dubois, Kazem Nasserinejad, Johan A Dobber, Clemens Mellink, Djamila E Issa

Lancet Haematol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time trends in primary therapy and relative survival of diffuse large B-cell lymphoma by stage: a nationwide, population-based study in the Netherlands, 1989-2018.
Müjde Durmaz, Otto Visser, Eduardus F M Posthuma, Rolf E Brouwer, Djamila E Issa

Blood Cancer J· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A population-based study on different regimens of R-CHOP in patients with newly diagnosed DLBCL in The Netherlands.
Djamila E Issa, Avinash G Dinmohamed, Marielle J Wondergem, Hedwig M Blommestein, Peter C Huijgens

Leuk Lymphoma· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Web-Based Self-Management for Patients With Lymphoma: Assessment of the Reach of Intervention of a Randomized Controlled Trial.
Lindy P J Arts, Simone Oerlemans, Eduardus F M Posthuma, Djamila E Issa, Margriet Oosterveld

J Med Internet Res· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment and relative survival in very elderly patients with DLBCL in The Netherlands: a population-based study, 1989 to 2015.
Avinash G Dinmohamed, Djamila E Issa, Marjolein W M van der Poel, Harry C Schouten, Pieternella J Lugtenburg

Blood Adv· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in incidence, treatment and survival of aggressive B-cell lymphoma in the Netherlands 1989-2010.
Djamila E Issa, Saskia A M van de Schans, Martine E D Chamuleau, Henrike E Karim-Kos, Marielle Wondergem

Haematologica· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of rituximab as maintenance treatment for relapsed follicular lymphoma: results of a population-based study.
Hedwig M Blommestein, Djamila E Issa, Marjolein Pompen, Gerhard Ten Hoor, Mels Hogendoorn

Eur J Haematol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life and persistent symptoms in relation to (R-)CHOP14, (R-)CHOP21, and other therapies among patients with diffuse large B-cell lymphoma: results of the population-based PHAROS-registry.
Simone Oerlemans, Djamila E Issa, Esther C van den Broek, Marten R Nijziel, Jan Willem W Coebergh

Ann Hematol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of therapy and disease-related symptoms on health-related quality of life in patients with follicular lymphoma: results of the population-based PHAROS-registry.
Simone Oerlemans, Djamila E Issa, Esther C van den Broek, Marten R Nijziel, Jan Willem W Coebergh

Eur J Haematol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A high level of fatigue among long-term survivors of non-Hodgkin's lymphoma: results from the longitudinal population-based PROFILES registry in the south of the Netherlands.
Simone Oerlemans, Floortje Mols, Djamila E Issa, J H F M Pruijt, Wim G Peters

Haematologica· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis